Name Symbol Market Type
Beximco Pharma LSE:BXP London Depository Receipt
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  +0.00 +0.00% 49.00 47.00 51.00 49.00 49.00 49.00 6,762 08:00:00

Beximco Pharma Discussion Threads

Showing 1526 to 1550 of 1550 messages
Chat Pages: 62  61  60  59  58  57  56  55  54  53  52  51  Older
DateSubjectAuthorDiscuss
09/7/2018
10:27
'Northland raises its price target for Beximco Pharma– Factoring in the Q3 2018 figures into our financial model, results in a higher full-year earnings forecast and lifts the share price target to 84p (from 75p previously). The current 38% discount of AIM-quoted shares relative to those on the local Dhaka exchange (DSE:BXPHAR) highlights this apparent undervaluation. Northland reiterates its Buy rating on Beximco Pharmaceuticals.'
mfhmfh
06/6/2018
08:25
That's what I thought, 10% ago but it just kept falling but having said that, looking at the chart there was a similar fall about this time last year that corrected itself in July . . ish so fingers crossed, I do like this company but am real disappointed about the complete lack of any promotional activity in the UK; they clearly rely only on institutional investors.
ginko3
05/6/2018
20:00
interesting fall here especially considering it's not mirrored on the dhaka stock exchange. may be a buying opportunity when share price fall settles.
mfhmfh
14/5/2018
15:28
Right, fall overdone now, I'm back in with £20ks worth - no reason why this shouldn't be back up to the 60 - 62p range in the next couple of days.
ginko3
27/4/2018
14:15
Solid 3rd quarter results. Northland Capital retain 75p target price.
mfhmfh
23/4/2018
17:43
Good volume today
mfhmfh
23/4/2018
10:52
positive RNS today. IMHO.
mfhmfh
18/4/2018
14:54
good volume today
mfhmfh
26/2/2018
18:04
Mine has arrived also.
jim208
26/2/2018
17:56
Received my dividend today
sharpish
22/2/2018
20:10
I have not received the divi yet - was wondering as its over a month since payment was due.
jim208
19/2/2018
17:21
Northland Capital: 75p target price
mfhmfh
17/2/2018
08:10
Anybody else having trouble getting their divi? It seems there is a problem converting the bdt to dollars.
rogash
30/1/2018
08:30
great half year results. company continuing to grow at a good rate. exports increasing. domestic sales increasing. cheap on a PE basis. one to hold long-term. All IMHO.
mfhmfh
30/1/2018
07:46
They seem fine to me, steady growth, eps 6p for full year, on a PE of 10 Seems somewhat cheap for a company growing at this rate.
chrisgail
30/1/2018
07:24
Half yearly results out -look decent to me. Would welcome other's thoughts.
firtashia
19/1/2018
09:01
acquisition completed: 'The acquisition will serve as a strong foundation for sustainable future growth, as well as enhancing near-term revenue growth for the Company.'
mfhmfh
22/12/2017
20:16
Thanks for that sharpish I sometimes use a crest sponsered account so that would have lead to a USD cheque in the post with all it's complications. it would be alot simpler to buy this in an ISA account. 3800
3800
22/12/2017
17:22
It isn't entirely straightforward - dividend is paid in USD and your broker will convert at the prevailing rate. Usually takes a few weeks after AGM to arrive.
sharpish
22/12/2017
15:17
when this company pays a dividend does it pay it in GBP in the normal way or is there any complications? thanks in advance. 3800
3800
22/12/2017
11:56
AGM tomorrow to approve acquisition
mfhmfh
14/11/2017
10:44
Still haven't found any earnings upgrades for FY18 since the prelims. Assuming that Q1 EPS are maintained for the rest of the year then thats going to beat those forecasts easily.
firtashia
13/11/2017
22:16
25% increase in eps for 1st quarter compared to 1st q 2016!
cockneytrader
07/11/2017
15:50
3800- just a consensus
firtashia
07/11/2017
13:42
Northland Capital have recently taken over as broker for BXP (from Daniel Stewart if memory serves). They released a note this morning (available on Research Tree) but unfortunately have not provided forecasts. 'Results and product launch into US This morning Beximco announced it has commenced the export of Sotalol Hydrochloride (80 mg, 120 mg and 160 mg), a generic version of the cardiovascular drug Betapace, to the US. Following the successful launch of Carvedilol to the US in August 2016, this is the second product from Beximco Pharma to be exported to the US. According to QuintlesIMS data, the market size for Satalol Hydrochloride (including all strengths) in the US is $23 million. Yesterday, Beximco also announced its audited results for the 12 month period ended 30 June 2017. Net sales increased to BDT 15,508.8 million (£147.51 million), registering year-on-year growth of 12.5% (2015-16: BDT 13,785.3 million (£135.7 million)) Export sales registered year-on-year growth of 25.2% Profit before tax increased 12.8% to BDT 2,891.5 million (£27.50 million), (2015-16: BDT 2,564.3 million, £25.24 million) Yesterday Beximco’s results demonstrated that the Company continues to see good YoY growth, registering double-digit Sales and PBT expansion. Of note, the Group continues to show strong export growth. Also, today’s announcement demonstrates Beximco’s continued progress in the US market, with the launch of its second product there.' https://www.research-tree.com/research/northland-capital-partners/northland-capital-partners-limited-morning-report/f99ea779-9dc1-47e9-a5e2-204c07532233
penpont
Chat Pages: 62  61  60  59  58  57  56  55  54  53  52  51  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20180715 19:53:41